文献
J-GLOBAL ID:201902290751957124
整理番号:19A2292628
ROS1再構成進行非小細胞肺癌(NSCLC)でのクリゾチニブ:PROFILE 1001からの全生存率を含む結果の更新
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001
著者 (14件):
SHAW A. T.
(Massachusetts General Hospital Cancer Center, Boston)
,
RIELY G. J.
(Memorial Sloan Kettering Cancer Center, New York, USA)
,
BANG Y.-J.
(Seoul National Univ. Coll. of Medicine, Seoul, KOR)
,
KIM D.-W.
(Seoul National Univ. Coll. of Medicine, Seoul, KOR)
,
CAMIDGE D. R.
(Univ. Colorado Cancer Center, Aurora, USA)
,
SOLOMON B. J.
(Peter MacCallum Cancer Centre, Melbourne, AUS)
,
VARELLA-GARCIA M.
(Univ. Colorado Cancer Center, Aurora, USA)
,
IAFRATE A. J.
(Massachusetts General Hospital Cancer Center, Boston)
,
SHAPIRO G. I.
(Dana-Farber Cancer Inst., Boston, USA)
,
USARI T.
(Pfizer Oncology, Milan, ITA)
,
WANG S. C.
(Pfizer Oncology, La Jolla)
,
WILNER K. D.
(Pfizer Oncology, La Jolla)
,
CLARK J. W.
(Massachusetts General Hospital Cancer Center, Boston)
,
OU S.-H. I.
(Univ. California, Irvine, USA)
資料名:
Annals of Oncology
(Annals of Oncology)
巻:
30
号:
7
ページ:
1121-1126
発行年:
2019年07月
JST資料番号:
W0107A
ISSN:
0923-7534
CODEN:
ANONE2
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
イギリス (GBR)
言語:
英語 (EN)